Ciprofloxacin Tablet 250mg (Ciprofloxacin Hydrochloride)

Adult dose

Typically for adults, 250 to 500 mg of ciprofloxacin is administered orally twice a day between meals. In cases of severe mixed infections, the dosage can be increased to 750 mg twice daily. For acute infections, treatment usually lasts 5 to 10 days, and at least 3 days more should be administered after symptoms have disappeared. In patients with renal impairment, the dosage must be adjusted based on creatinine clearance; for severe infections, a single dose can be increased up to 750 mg.

This drug may cause serious side effects such as tendinitis or tendon rupture; therefore, if such symptoms occur, it should be discontinued immediately. Particularly in patients with myasthenia gravis, using this drug may worsen symptoms, so it should not be administered. Pregnant women or women who may become pregnant, breastfeeding women, children and adolescents under 18 years of age, and patients with epilepsy should not use this drug. Moreover, co-administration with certain medications (e.g., tizanidine, ketoprofen) may increase the risk of side effects, so they should be avoided. Elderly patients or those with severely impaired renal function, or patients with a history of seizures should use this drug cautiously and be closely monitored. This medication can affect the central nervous system, leading to dizziness, seizures, and mental confusion, necessitating caution. During treatment, care should be taken to avoid strong sunlight or artificial ultraviolet exposure; if skin rash or itching occurs, use should be immediately stopped. Diabetic patients with poor blood sugar control should closely monitor blood sugar changes, and if hypoglycemic symptoms appear, immediate treatment should be conducted. Additionally, this medication can interact with various drugs; therefore, if other medications are taken, it is essential to inform healthcare professionals. If neurological symptoms such as pain, sensory disturbances, or changes in vision occur during treatment, consult a specialist immediately. Overdose may affect kidney function; thus, in emergencies, proper care should be received promptly. This drug should be stored out of reach of children and protected from direct sunlight or ultraviolet light.

Serious side effects

Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, worsening of myasthenia gravis, anaphylactic reactions, anaphylactoid reactions, shock, serum sickness-like reactions, seizures, status epilepticus, psychotic reactions (including suicidal thoughts and suicide attempts), coma, life-threatening adverse reactions, pseudomembranous colitis, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, hepatic necrosis, life-threatening hepatic failure

Mild side effects

Fungal superinfections, blood and lymphatic system adverse reactions (eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocytopenia, hemoglobin decrease, hematocrit decrease, granulocyte decrease, leukocyte lysis), appetite loss, increased alkaline phosphatase in blood, hyperglycemia, hypoglycemia, lipase increase, abnormal prothrombin levels, increased amylase,

This drug should be stored in a tightly closed container to protect it from air and moisture, and the storage temperature should be maintained between 1 and 30 degrees Celsius at room temperature. Storing in this manner will help to maintain the drug's efficacy for a longer time.

Appearance

White to pale yellow round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle